Bio-Reference Laboratories Inc  

(Public, NASDAQ:BRLI)   Watch this stock  
Find more results for BRLI
-0.18 (-0.66%)
Apr 15 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 26.78 - 27.60
52 week 23.41 - 37.97
Open 27.57
Vol / Avg. 227,915.00/333,291.00
Mkt cap 754.72M
P/E 18.89
Div/yield     -
EPS 1.44
Shares 27.72M
Beta 0.94
Inst. own 90%
Jul 7, 2014
Bio-Reference Laboratories, Inc. Annual Shareholder Meeting (Estimated) Add to calendar
Jun 2, 2014
Q2 2014 Bio-Reference Laboratories, Inc. Earnings Release (Estimated) Add to calendar
Mar 19, 2014
Bio-Reference Laboratories, Inc. at Bank of America Merrill Lynch Smid Cap Conference
Mar 4, 2014
Q1 2014 Bio-Reference Laboratories, Inc. Earnings Conference Call - Webcast
Mar 4, 2014
Q1 2014 Bio-Reference Laboratories, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '14) 2013
Net profit margin 1.63% 6.41%
Operating margin 3.24% 11.46%
EBITD margin - 14.22%
Return on average assets 2.79% 12.48%
Return on average equity 4.34% 18.37%
Employees 3,338 -
CDP Score - -


481 Edward H. Ross Drive
ELMWOOD PARK, NJ 07407-3118
United States - Map
+1-201-7912600 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Bio-Reference Laboratories, Inc. (Bio-Reference) is a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women�s health and correctional health care. The Company has a network f approximately 116 patient service centers located in the Northeast (primarily in New York metropolitan super-regional area) for collection of patient specimens. In August 2013, Bio-Reference Laboratories Inc completed the acquisition of a clinical laboratory in northern California. The Company acquired most of the assets of Hunter Laboratories, located in the Bay area.

Officers and directors

Marc D. Grodman M.D. Chairman of the Board, President, Chief Executive Officer
Age: 62
Bio & Compensation  - Reuters
Sam Singer Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Director
Age: 70
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Howard Dubinett Chief Operating Officer, Executive Vice President, Director
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joseph Benincasa Independent Director
Age: 64
Bio & Compensation  - Reuters
Harry Elias Independent Director
Age: 83
Bio & Compensation  - Reuters
Gary Lederman Esq. Independent Director
Age: 79
Bio & Compensation  - Reuters
John Roglieri M.D. Independent Director
Age: 74
Bio & Compensation  - Reuters